Dr. Darko Jordanovski

I hold a natural sciences doctorate, so I am used to breaking down complex issues into “bite-size” packets and defining specific analytical priorities so as to obtain quantifiable results. I’ve always been interested in how it occurs that normally well-functioning systems at some point become misaligned, and then in particular how these problems are resolved. At Struktur Management Partner I have been able to study such questions in a business and turnaround context since joining the firm in 2014. When I came to Struktur Management Partner I had some executive education and a certificate under my belt as well as some project management experience, and was looking to build on this valuable basis by learning about SMEs and consulting, thinking I would probably move on after a couple of years ... But I have found the work at this firm to be very meaningful on a personal level and I love the focus on implementation here, so I stay on! In my role today I generally get involved after things have gotten serious, in more demanding projects where I am often active in questions of court-ordered versus out-of-court restructuring.

• Designing and executing turnaround and earnings enhancement projects for larger mid-sized corporations
• Designing 360-degree turnaround programmes (including IDWS6)
• Corporate finance, managing projects of a more demanding nature
• Court-ordered restructuring (primarily under the “self-administration” and “protective shield” legal principles)
• Main industries: Mechanical and industrial engineering, automotive, renewable energies

• Many years’ experience managing reorganisations, completing more than 25 projects within the last eight years
• IPMA project management certification

• Der präventive Restrukturierungsrahmen, the legal framework for preventive restructuring.
• ZNF395 Is an Activator of a Subset of IFN-Stimulated Genes; Mediators Inflamm. 2017; 2017: 1248201; Linda Schroeder, Christine Herwartz, Darko Jordanovski, and Gertrud Steger (2017)
• The Hypoxia-Inducible Transcription Factor ZNF395 Is Controlled by IĸB Kinase-Signaling and Activates Genes Involved in the Innate Immune Response and Cancer PLoS One. 2013; 8(9): e74911. Darko Jordanovski, Christine Herwartz, Anna Pawlowski, Stefanie Taute, Peter Frommolt, and Gertrud Steger (2013)
• ZNF395 (HDBP2/PBF) is a Target Gene of Hif-1α; Huntington's Disease - Core Concepts and Current Advances; ISBN: 978-953-307-953-0; InTech, 2012; Darko Jordanovski, Christine Herwatz and Gertrud Steger (2012)